Hyperphosphataemia—a silent killer of patients with renal failure?

Open Access
Publisher Website
Google Scholar
Abstract
For decades, it has been known that patients with end-stage renal failure have an excessive coronary and cardiac risk. There is also widespread consensus that coronary atherosclerosis and its complications are not fully explained by classical risk factors, e.g. dyslipidaemia, elevated homocysteine concentrations, hypertension, insulin resistance, high fibrinogen etc.